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Embryonic/fetal mortality and 
intrauterine growth restriction is not 
exclusive to the CBA/J sub-strain  
in the CBA × DBA model
Kelly J. McKelvey1,2, Vanessa M. Yenson1,2, Anthony W. Ashton1,2, Jonathan M. Morris1,2,3 & 
Sharon A. McCracken1,2
Inbred strains of mice are powerful models for understanding human pregnancy complications. For 
example, the exclusive mating of CBA/J females to DBA/2J males increases fetal resorption to 20–35% 
with an associated decline in placentation and maintenance of maternal Th1 immunity. More recently 
other complications of pregnancy, IUGR and preeclampsia, have been reported in this model. The aim 
of this study was to qualify whether the CBA/CaH substrain female can substitute for CBA/J to evoke 
a phenotype of embryonic/fetal mortality and IUGR. (CBA/CaH × DBA/2J) F1 had significantly higher 
embryonic/fetal mortality mortality (p = 0.0063), smaller fetuses (p < 0.0001), and greater prevalence 
of IUGR (<10th percentile; 47% vs 10%) than (CBA/CaH × Balb/c) F1. Placentae from IUGR fetuses from 
all mating groups were significantly smaller (p < 0.0001) with evidence of thrombosis and fibrosis when 
compared to normal-weight fetuses ( > 10th percentile). In addition, placentae of “normal-weight” 
(CBA/CaH × DBA/2J) F1 were significantly smaller (p < 0.0006) with a greater proportion of labyrinth 
(p = 0.0128) and an 11-fold increase in F4/80 + macrophage infiltration (p < 0.0001) when compared to 
placentae of (CBA/CaH × Balb/c) F1. In conclusion, the embryonic/fetal mortality and IUGR phenotype 
is not exclusive to CBA/J female mouse, and CBA/CaH females can be substituted to provide a model for 
the assessment of novel therapeutics.
In the last century there has been a vast improvement in overall perinatal health. However, high rates of perinatal 
mortality and morbidity persist in spite of advances in medical technologies and management, such as routine use 
of ultrasound to monitor fetuses during pregnancy. An important cause of perinatal mortality, secondary only to 
preterm birth, is the failure of the fetus to reach its growth potential in utero, termed intrauterine growth restric-
tion (IUGR); defined by the World Health Organisation as an estimated fetal weight below the 10th percentile of 
the recommended gender-specific birth weight for gestational age reference curve1. Worldwide, IUGR affects 
7–15% of pregnancies2,3 and has an 8–10-fold greater risk of perinatal mortality when compared to pregnancies 
with a normal-weight fetus4.
Mouse models are a powerful tool for understanding pregnancy outcomes, as well as embryonic and placental 
growth and development. Mice and humans share physiological characteristics during both healthy pregnancy 
and those with adverse outcomes including immunological, hormonal, and fetal/placental development. While 
animal models created by genetic, surgical and pharmacological manipulation are highly valuable for study-
ing the pathogenesis of IUGR, these models inadvertently introduce confounding factors when utilised for the 
assessment and development of new therapeutics. In contrast, the CBA/J × DBA/2J murine model5 spontaneously 
develops IUGR and embryonic/fetal mortality6,7 and shares features of the human IUGR complication, includ-
ing inadequate maternal arterial remodelling at the implantation sites8,9 and utero-placental dysregulation with 
complement deposition on trophoblasts, increased inflammatory cell infiltration (neutrophil and monocyte) and 
tumour necrosis factor (TNF)-α expression in maternal decidua6,10,11.
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Since identification of the abortion-prone phenotype in pregnant DBA/2J-mated CBA/J female mice in 1980, 
subsequent studies reported that this phenotype is exclusive to the American Jackson Laboratory-derived CBA/J 
female, with other CBA sub-strains (CBA/Ca, CBA/JHan, CBA/N) showing normal incidence12,13. This was 
believed to arise from semi-allogeneic rejection of the placenta by maternal immune cells due to differences in the 
murine major histocompatibility antigen, termed H-2 antigens which have accumulated by the separate breeding 
lines since 193513,14; CBA/J (H2k, Mlsd) and CBA/Ca and CBA/N (H2k, Mlsb). However, ‘genetic drift’ may, in 
part, explain why more recent papers have identified new phenotypes in the CBA/J × DBA/2J model including 
fetal growth restriction6 and immunologically-mediated pre-eclampsia at mid gestation (15.5 dpc)7,15, though 
neither phenotype has been replicated in a term population (17.5–18.5 dpc)16.
As CBA/J mice are not currently available in Australia, and CBA/J and CBA/CaJ mice show differences in 
aging phenotypes17 we examined whether the Commonwealth-derived CBA/CaH.Arc mouse (Animal Resource 
Centre, Murdoch, Australia) can substitute for the American-derived CBA/J sub-strain in the spontaneous 
CBA × DBA/2J murine model. In this study we show that the CBA/CaH pregnant female develops an IUGR and 
embryonic/fetal mortality phenotype at mid-gestation (14.5 dpc) following allogeneic mating with DBA/2J males, 
suggesting that this sub-strain can be substituted where CBA/J mice are not available.
Results
To establish whether CBA/CaH × DBA/2J pregnancies show the same propensity for embryonic/fetal mortal-
ity and IUGR as CBA/J females, 150 CBA/CaH females were placed with DBA/2J, Balb/c or CBA/CaH males 
overnight. Both mid-gestation (14.5 dpc, n = 20 matings per group) and term (18.5 dpc, n = 30 matings per 
group) time points were assessed to directly compare the fetal outcomes. Harvesting of gravid uteri, including 
the cervix, revealed the presence of resorption sites but showed no macroscopic uterine abnormalities in CBA/
CaH × DBA/2J pregnancies at mid-gestation (Fig. 1a) or term (Fig. 1b).
Embryonic/fetal mortality is increased in CBA/CaH × DBA/2J pregnancies. The severest form of IUGR 
in our cohort is reflected as embryonic/fetal mortality (resorption). Overall, there was a significant increase in (CBA/
CaH × DBA/2J) F1 embryonic/fetal mortality in when compared to (CBA/CaH × Balb/c) F1 at term (21.1 ± 2.4% vs 
10.7 ± 2.9%, p = 0.0079; Fig. 2a), while mid-gestation did not reach significance (22.6 ± 3.89% vs 8.5 ± 5.89, p = 0.1569). 
Mortality in the (CBA/CaH × DBA/2J) F1 ranged widely from 0 to 63.4% at mid-gestation and between 0 to 55.5% 
in term populations, indicating that not all pregnancies are affected. This was particularly evident at term with 86.7% 
of CBA/CaH × DBA/2J litters containing resorptions, compared to 45.8% CBA/CaH × Balb/c and 79.2% for CBA/
CaH × CBA/CaH pregnancies (Χ 2 = 11.91, p = 0.0026). There was no statistical difference at mid-gestation.
Figure 1. Macroscopic pregnancy outcomes of murine CBA/CaH × DBA/2J pregnancies. Representative 
photographs of gravid uteri harvested from CBA/CaH × Balb/c, CBA/CaH × CBA/CaH and CBA/
CaH × DBA/2J pregnancies at (a) 14.5 dpc (N = 20 dams per strain) and (b) 18.5 dpc (N = 30 dams per strain). 
Fetuses and placentae were excised, measured, weighed and photographed. Weights of fetuses, placentae and 
resorptions are indicated in grams. Asteri denote resorption sites indicating embryonic/fetal mortality.
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Descriptors of the progression of resorption are ‘embryonic’, ‘bag of cells’ and ‘clot’ phases18, reflecting pro-
gressive loss of the fetal and placental structures via aseptic intravital autolysis. In our study evidence of all three 
stages was present, irrespective of the group analysed, with the clot phase most common in mid-gestation (70/72, 
97.2%) and term (84/96, 87.5%) pregnancies. Embryonic phase resorptions were observed at term (6/96, 6.3%), 
but not mid-gestation, and were primarily associated with (CBA/CaH × Balb/c) F1 potentially indicating that 
fetal death and resorption takes place at a later time point in these pregnancies.
A range of factors have been found to influence embryonic/fetal mortality in mice and specifically the 
CBA/J × DBA/2J murine model. These include maternal nutrition, primigravidity, immunological environ-
ment, maternal age and overcrowding of one uterine horn19,20. However, irrespective of time-point we found 
no differences in maternal weight gain, uteri wet weight, or total number of concepti when compared to CBA/
CaH × Balb/c (Fig. 2). The number of concepti in left vs right uterine horns of CBA/CaH × DBA/2J pregnancies 
was uneven (≥ 2 concepti difference between left and right horns; Χ 2 = 7.370, p = 0.0251) when compared to 
CBA/CaH × Balb/c, but the ‘overcrowded’ horn was not associated with greater mortality when compared to the 
‘uncrowded’ horn (Χ 2 = 2.249, p = 0.3248; and shown Fig. 1).
While mortality rates did not differ, we considered whether CBA/CaH × DBA/2J pregnancies have abnormal 
spacing between implantation sites which may impact placental development leading to the increased mortality 
we observed. Using the incidence of diamniotic/dichorionic (placentally-fused) twins as a surrogate for abnor-
mal implantation site, at term the incidence of twins was 3.6% (6/168) in (CBA/CaH × Balb/c) F1, 2.2% (4/183) 
in (CBA/CaH × CBA/CaH) F1, and 3.5% (8/230) in (CBA/CaH × DBA/2J) F1 and not statistically significant 
(Χ 2 = 0.7434, p = 0.6895). Of the observed twin fetuses 50%, 25% and 25% respectively were asymmetrical 
(different size fetuses; example shown in Fig. 2e). At mid-gestation only one instance of diamniotic/dichorionic 
twins was observed in a CBA/CaH × DBA/2J pregnancy. These data suggest that overcrowding, with or without 
abnormal spacing, was not a significant contributing factor to the increased embryonic/fetal mortality observed 
in (CBA/CaH × DBA/2J) F1 and (CBA/CaH × CBA/CaH) F1.
Proportion of IUGR fetuses is increased in CBA/CaH × DBA/2J pregnancies. Studies using the 
CBA/J × DBA/2J murine model have reported that surviving fetuses show consistent and significant ‘IUGR’6, 
based on a statistical reduction in average fetal weight. To utilise a biologically relevant criterion for IUGR, we 
quantified the prevalence of IUGR in our murine pregnancies using the human clinical definition of < 10th per-
centile for gestational age, with fetuses from allogeneic (CBA/CaH × Balb/c) F1 as the population standard. Fetal 
wet weight and crown-rump length (CRL)21 were assessed and demonstrated a strong correlation at both time 
points (14.5 dpc r = 0.77 to 0.89; p = 0.0406 to p < 0.0001; and 18.5 dpc r = 0.91 to 0.94, p < 0.0001 Fig. 3a).
Figure 2. Maternal characteristics of the murine CBA/CaH × DBA/2J pregnancies. (a) Embryonic/
fetal mortality (resorption) rate, (b) maternal body weight at mating, (c) uterine wet weight, and (d) number 
of concepti at 14.5 dpc (N = 20 dams per strain) and 18.5 dpc (N = 30 dams per strain). (e) Representative 
photograph of asymmetrical diamniotic/dichorionic (placentally fused) twins. All data are represented as 
mean ± SEM. **p < 0.01 vs value for CBA × Balb/c by One-way ANOVA with Tukey’s multiple comparison test.
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Using our definition, IUGR fetuses were denoted as those with a wet weight < 0.1427g and < 0.4725g 
and/or CRL < 9.75 mm and < 14.75 mm at 14.5 and 18.5 dpc, respectively. At mid-gestation, 47% of (CBA/
CaH × DBA/2J) F1 fell below the 10th percentile confirming a substantial IUGR phenotype at this time point 
(Fig. 3b). From 20 pregnant dams this equated to 46 IUGR fetuses, compared to 31 for (CBA/CaH × CBA/CaH) 
F1 and 13 for (CBA/CaH × Balb/c) F1. The number of IUGR fetuses dropped markedly at term with only 5–6 
IUGR fetuses in all pregnancy groups. In contrast, the number of resorptions at term remained high; 46 in (CBA/
CaH × DBA/2J) F1, 24 in (CBA/CaH × CBA/CaH) F1 and 14 in (CBA/CaH × Balb/c) F1. We propose that IUGR 
fetuses present at 14.5 dpc become non-viable by term (present as resorptions) resulting in a ‘perceived’ absence 
of IUGR at term in the CBA/CaH × DBA/2J pregnancies. There is precedence for this, with pregnant mice treated 
with 6 mg of the yeast extract Malucidin at 16–17 dpc, showing complete resorption of a fetus after 48 hr22. Even 
in large mammals, such as dogs, complete resorption of a fetus takes only 2–5 days and is preceded by reduced 
growth and/or development of the embryo and fetus23.
Placentae from IUGR fetuses show histopathology. Macroscopically, the murine IUGR fetuses 
were developmentally delayed with smaller, thinner and/or pale placentae in comparison to normal-weight lit-
termates (> 10th percentile; Fig. 4a). Quantitation of placental characteristics confirmed that IUGR placentae 
from (CBA/CaH × DBA/2J) F1 weighed on (mean) average 24% less at mid-gestation (p = 0.011) and 47% less 
at term (p < 0.0001) than their normal-weight littermates (Fig. 4b). Representative histological sections of IUGR 
placentae are shown in Fig. 4c (c.f. normal-weight in Fig. 4e). Evidence of pathological changes including throm-
bosis and fibrosis were present in placentae from IUGR fetuses of all groups (Fig. 4d), consistent with placental 
patho-histological observations of human IUGR placentae24,25.
Among the IUGR fetuses of all strains there were no differences in placental dimension at either time point 
(Table 1). In mice the primary site of feto-maternal exchange is the labyrinth, with the maternal decidua provid-
ing anchorage to the uterine wall and the fetal chorionic plate delivering blood to/from the umbilical cord. The 
proportion of IUGR placentae dedicated to the labyrinth layer was significantly less in (CBA/CaH × DBA/2J) F1 
compared to (CBA/CaH × CBA/CaH) F1 and (CBA/CaH × Balb/c) F1 at mid-gestation, but did not reach signifi-
cance at term (Table 1, and see Fig. 4f for colour rendering of placental layers). The trophospongium and maternal 
decidual layers were highly variable among the (CBA/CaH × DBA/2J) F1 cohort at 14.5 dpc indicating there may 
be a range of dysfunction among the placentae in this cohort (i.e. mild, moderate, severe).
One indicator of placental function, or the efficiency of placental nutrient transport, is the ratio of fetal wet 
weight to placental wet weight in grams26. In addition, with the placenta acting as a nutrient sensor and storage 
site for glucose (as glycogen) during pregnancy, we sought to determine whether there are changes in the propor-
tion of glycogen-containing cells, and by extension the energy repository, available for fetal growth and develop-
ment of (CBA/CaH × DBA/2J) F1. There was no significant difference in placental efficiency or the proportion of 
glycogen-containing cells at either time point between the (CBA/CaH × DBA/2J) F1 and (CBA/CaH × Balb/c) 
F1 IUGR placentae, although trends toward reduced efficiency and glycogen storage were present (Table 1). 
Meanwhile, the IUGR placentae of (CBA/CaH × CBA/CaH) F1 showed the highest placental efficiency of the 
three strains (Table 1).
Comparison of placental morphology in IUGR and normal-weight fetuses. Normal-weight data 
is provided in Table 2 and micrographs in Fig. 4e. The p-values for the statistical comparison between placen-
tae of IUGR and normal-weight fetuses of the same strain are provided in Supplementary Table I. Consistent 
with reduced placental weight, the IUGR placentae of all strains were significantly smaller in dimension (diam-
eter, thickness and/or cross-sectional midline area) than their normal-weight littermates with the differences 
more pronounced at term than mid-gestation (Fig. 4a,e, and Supplementary Table I). When compared to 
normal-weight fetuses at mid-gestation, the placentae of IUGR fetuses from (CBA/CaH × DBA/2J) F1, but not 
the other strains, had smaller labyrinth (39.7 vs 52.4%, p < 0.0001) and larger trophospongium (41.4 vs 24.7%; 
p < 0.0001) (Supplementary Table I). Combined with the aforementioned analysis of placental structure of 
Figure 3. Fetal characteristics of the murine CBA/CaH × DBA/2J model. Fetuses were excised from gravid 
uteri at 14.5 and 18.5 dpc. (a) Crown-rump length showed a strong positive correlation with fetal wet weight. 
(b) Distribution of fetal crown-rump length for all strains where a length < 10th percentile of (CBA × Balb/c) F1 
were denoted as intrauterine growth restricted (IUGR; b). ***p = 0.005. ****p < 0.0001 vs (CBA × Balb/c) F1 by 
One-way ANOVA with Tukey’s multiple comparison test.
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IUGR placentae, this may indicate that although each strain has IUGR fetuses, the histopathology of the (CBA/
CaH × DBA/2J) F1 IUGR fetuses is more severe at this time point.
At term all strains demonstrated significantly greater placental efficiency for normal-weight fetuses compared 
to IUGR (all p < 0.0001; Table 1), though only the (CBA/CaH × Balb/c) F1 IUGR placentae showed differences 
in placental layer composition compared to normal-weight fetuses; less labyrinth (48.6 vs 63.5%; p < 0.0001), and 
larger trophospongium ( 29.1 vs 19.8%; p < 0.0001), maternal decidua (22.3 vs 16.7%; p = 0.0004) and glycogen 
storage (14.1 vs 9.5%; p < 0.0001; Table 1).
Normal-weight fetuses of CBA/CaH × DBA/2J pregnancies show placental abnormalities. The 
increase in embryonic/fetal mortality, IUGR and abnormal placental structure in (CBA/CaH × DBA/2J) F1 
IUGR placentae raised the question of whether there are also perturbations of the placenta evident for fetuses 
that macroscopically appear normal and have normal weight. In short, is there a predisposition in the (CBA/
CaH × DBA/2J) F1 placenta that leads to IUGR and embryonic/fetal mortality? In the normal-weight fetal popu-
lation, placentae from (CBA/CaH × DBA/2J) F1 were significantly smaller in diameter (p < 0.0001) and midline 
cross-sectional area (p = 0.0006) at term and significantly higher proportion of labyrinth and lower proportion 
of trophospongium at mid-gestation and term, when compared to (CBA/CaH × Balb/c) F1 (Fig. 4e and Table 2). 
Therein while these fetuses still achieved a normal body weight there are notable differences in the morphology 
of their placentae which may impact placental function.
Despite having reduced total placental area and greater proportion of labyrinthine layer (Table 2), which 
may have suggested altered surface area for feto-maternal exchange, there was no difference in placental effi-
ciency between the placentae of (CBA/CaH × DBA/2J) F1 and normal-weight (CBA/CaH × Balb/c) F1 
(Table 2). At mid-gestation, but not term, the placentae from (CBA/CaH × DBA/2J) F1 contained 55% more 
Figure 4. Macroscopic and histological characteristics of murine placentae from IUGR and normal-
weight fetuses in the CBA/CaH × DBA/2J model. (a) Representative photograph of IUGR (< 10th %) and 
normal-weight (> 10th %) littermates at 14.5 dpc (left) and 18.5 dpc (right). (b) Placentae weight for IUGR and 
normal-weight fetuses represented as mean ± SEM. (c) PAS-stained sections of resorptions and placentae from 
IUGR fetuses (14.5 dpc) were assessed for differences in placental dimensions and the proportion devoted to 
the labyrinth, trophospongium and maternal decidua. (d) Comparison of normal labyrinthine tissue and areas 
of thrombotic (dotted line) and fibrotic tissue (asteri; presence of blue/green collagen) from IUGR associated 
placentae stained with fast-green Masson’s trichrome. (e) PAS-stained sections of placentae from normal-weight 
fetuses at 14.5 and 18.5 dpc, and (f) a (CBA/CaH × Balb/c) F1 fetuses at 18.5 dpc placentae that has been colour 
rendered to show the placental layers quantitated in Table 2. (b) **p < 0.01, ***p < 0.001 vs CBA × CBA by One-
way ANOVA with Tukey’s multiple comparison test; †p < 0.05 vs value for IUGR by unpaired two-tailed Student 
T test.
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14.5 dpc ANOVA
CBA × Balb/c CBA × CBA CBA × DBA p-value
Placentae (N) 13 31 46
Diameter (mm) 8.30 ± 0.34 7.06 ± 0.29 6.99 ± 0.94 0.8478
Thickness (mm) 2.28 ± 0.11 2.21 ± 0.317 3.66 ± 0.04 0.1177
Area (mm2) 19.37 ± 1.03 14.32 ± 1.94 21.52 ± 3.97 0.1541
Labyrinth (%) 51.34 ± 2.54a 62.03 ± 2.67af 39.69 ± 2.28 0.0006
Trophospongium (%) 25.64 ± 2.36 18.09 ± 1.38a 41.39 ± 8.51 0.0229
Maternal decidua (%) 23.01 ± 1.37 19.88 ± 1.28 18.91 ± 10.74 0.4961
Placental efficiency (fetal/
placental weight) 1.72 ± 0.02 1.87 ± 0.16
ae 1.20 ± 0.17 0.0084
Glycogen-containing cells (% 
placenta) 10.84 ± 0.0 15.86 ± 1.19
c 9.85 ± 1.24 0.0022
18.5 dpc ANOVA
Placentae (N) 5 6 6
Diameter (mm) 7.63 ± 0.28 7.36 ± 0.55 6.83 ± 0.59 0.1883
Thickness (mm) 2.42 ± 0.18 2.33 ± 0.06 2.07 ± 0.20 0.6188
Area (mm2) 18.71 ± 2.33 15.64 ± 1.47 12.83 ± 1.55 0.1240
Labyrinth (%) 48.64 ± 2.99 64.25 ± 3.25 60.81 ± 5.11 0.0529
Trophospongium (%) 29.08 ± 4.37 19.45 ± 1.72 24.16 ± 2.39 0.0691
Maternal decidua (%) 22.29 ± 2.39 16.31 ± 2.85 18.07 ± 5.19 0.2443
Placental efficiency (fetal/
placental weight) 1.21 ± 0.27 1.82 ± 0.53 0.60 ± 0.37 0.1761
Glycogen-containing cells (% 
placenta) 14.14 ± 2.25 8.74 ± 0.79
d 9.78 ± 1.14 0.0319
Table 1.  Characteristics of placentae from IUGR fetuses. Data are expressed as mean ± SEM. ap < 0.05, 
bp < 0.01, cp < 0.001 vs (CBA/CaH × DBA/2J) F1; dp < 0.05, ep < 0.01, fp < 0.001 vs (CBA/CaH × Balb/c) F1 by 
One-way ANOVA with Tukey’s multiple comparison test. For each placentae two parallel sections taken 100 μ m 
apart were analysed.
14.5 dpc ANOVA
CBA × Balb/c CBA × CBA CBA × DBA p-value
Placentae (N) 34 35 36
Diameter (mm) 8.84 ± 0.35 8.85 ± 0.14 9.17 ± 0.14 0.2810
Thickness (mm) 2.67 ± 0.07 2.46 ± 0.04a 2.63 ± 0.05 0.0250
Area (mm2) 23.97 ± 1.01 22.35 ± 0.60 23.92 ± 0.69 0.1809
Labyrinth (%) 48.10 ± 1.09a 54.83 ± 0.96af 52.44 ± 0.80d 0.0006
Trophospongium (%) 28.61 ± 0.61a 23.46 ± 0.71f 24.75 ± 0.71d 0.0012
Maternal decidua (%) 23.29 ± 0.71 21.71 ± 0.83 22.81 ± 0.74 0.4442
Placental efficiency (fetal/
placental weight) 1.86 ± 0.03 2.25 ± 0.14
e 2.447 ± 0.36 0.0068
Glycogen-containing cells (% 
placenta) 10.00 ± 0.72 8.19 ± 0.53
c 12.68 ± 0.98 0.0004
18.5 dpc ANOVA
Placentae (N) 50 44 46
Diameter (mm) 10.38 ± 0.093c 9.69 ± 0.09f 9.45 ± 0.15f <0.0001
Thickness (mm) 2.72 ± 0.03 2.50 ± 0.04e 2.65 ± 0.04 0.0063
Area (mm2) 26.05 ± 0.40c 21.58 ± 0.50f 23.22 ± 0.56f < 0.0001
Labyrinth (%) 63.51 ± 0.64a 48.64 ± 2.99af 65.78 ± 0.97d < 0.0001
Trophospongium (%) 19.79 ± 0.49 16.96 ± 0.52e 18.82 ± 0.59 0.0088
Maternal decidua (%) 16.66 ± 0.38 14.01 ± 0.55e 15.53 ± 0.68 0.0094
Placental efficiency (fetal/
placental weight) 10.00 ± 0.24 11.20 ± 0.25
e 10.41 ± 0.26 0.0055
Glycogen-containing cells (% 
placenta) 9.47 ± 0.16 8.60 ± 0.30
e 9.23 ± 0.38 0.0077
Table 2.  Characteristics of placentae from normal-weight fetuses. Data are expressed as mean ± SEM. 
ap < 0.05, bp < 0.01, cp < 0.001 vs (CBA/CaH × DBA/2J) F1; dp < 0.05, ep < 0.01, fp < 0.001 vs (CBA/
CaH × Balb/c) F1 by One-way ANOVA with Tukey’s multiple comparison test. For each placentae two parallel 
sections taken 100 μ m apart were analysed.
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glycogen-containing cells compared to placentae from (CBA/CaH × CBA/CaH) F1 (p = 0.0009) and 27% more 
than (CBA/CaH × Balb/c) F1 (p = 0.09; Fig. 4e and Table 2). Placentae from (CBA/CaH × CBA/CaH) F1 had the 
lowest proportion of glycogen-containing cells at both 14.5 (8.19 ± 0.53%) and 18.5 dpc (8.60 ± 0.29%; Table 2), 
consistent with the lowest placental weights for normal-weight fetuses (Fig. 4b). Whether these differences in 
glycogen-storage are causal for reduced fetal growth or compensatory is unclear.
A hallmark of placentae from IUGR pregnancies is marked inflammatory infiltrate11. While macrophages 
and T-lymphocytes are required for normal placentation, excessive and/or prolonged inflammation contributes 
to the pathology of IUGR by damaging the fetal-maternal interface, promoting trophoblast cell death9,10,27. At 
mid-gestation placentae from (CBA/CaH × DBA/2J) F1 normal-weight fetuses contained significantly more 
CD3+ T-lymphocytes than (CBA/CaH × CBA/CaH) F1 (1.4-fold, p < 0.01) or (CBA/CaH × Balb/c) F1placentae 
(2.6-fold, p < 0.0001; Fig. 5a). While the absolute number of CD3+ T-lymphocytes was higher in all groups at 
term, intriguingly there was 1.5-fold more CD3+ T-lymphocytes in (CBA/CaH × Balb/c) F1 placentae than 
(CBA/CaH × CBA/CaH) F1 and (CBA/CaH × DBA/2J) F1 placentae (both p < 0.0001). In all groups and time 
points > 85% of CD3+ T-lymphocytes localised to the labyrinth (Fig. 5b). Subsequent analysis for CD4+ helper 
T-lymphocytes and CD8+ CTLs showed that while the absolute number of CD3+ T-lymphocytes differed among 
the groups, the proportion of CD4+ helper vs CD8+ CTLs was not significantly different; > 83% CD4+ helper 
T-lymphocytes at mid gestation and > 74% at term (Fig. 5c).
Figure 5. Inflammatory infiltrate of murine placentae from normal-weight fetuses at 14.5 and 18.5 dpc. 
(a) Representative micrograph and quantitation of CD3+T-lymphocytes in placentae and (b) their distribution 
among the placental layers. (c) The proportion of CD4+ helper T-lymphocytes and CD8+ CTLs to the placental 
T-lymphocyte infiltrate. (d) Representative micrograph and quantitation of F4/80+ macrophages and (e) their 
distribution among the placental layers. In (a–c) micrographs from placentae of (CBA/CaH × Balb/c) F1 
fetuses at 18.5 dpc are shown to demonstrate positive staining of the immune cell types. Data are represented as 
mean ± SEM. N = 34–50 placentae/strain/dpc as outlined in Table 2. **p < 0.01, ****p < 0.0001, as indicated by 
One-way ANOVA with Tukey’s multiple comparison test.
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Two populations of F4/80+ macrophages are present in placenta; maternal haematopoietic-derived mac-
rophages and fetal yolk sac-derived macrophages (Hofbauer cells)28. In addition to differences in origin, fetal 
macrophages predominantly localise to the chorionic villi (labyrinth in mice) and fetal circulation, and maternal 
macrophages to the maternal decidua28. (CBA/CaH × DBA/2J) F1 placentae had 1.8- fold more F4/80+ mac-
rophages than (CBA/CaH × Balb/c) F1 placentae at mid-term and 11-fold more at term (Fig. 5d). These changes 
were also mimicked in (CBA/CaH × CBA/CaH) F1. Within the placentae, 30–50% of macrophages localised to 
labyrinth and 50–70% to the fetal circulation (chorionic plate; Fig. 5e). Our data shows that there is altered tem-
poral and spatial distribution of T-lymphocyte and macrophages even in the placentae (CBA/CaH × DBA/2J) F1 
fetuses that achieve a normal-weight.
Discussion
The data in this study demonstrates that the IUGR and embryonic/fetal mortailty phenotype of the 
CBA/J × DBA/2J model can also be elicited by using the Commonwealth-derived CBA/CaH substrain. First, 
prevalence of IUGR and mortality was higher at 14.5 dpc in (CBA/CaH × DBA/2J) F1 than (CBA/CaH × Balb/c) 
F1. Second, in all strains IUGR fetuses were associated with lighter, smaller placentae with histopathology and 
reduced materno-fetal exchange as evidenced by smaller labyrinth and lower placental efficiencies when com-
pared to normal-weight fetuses of the same strain. Finally, despite some fetuses obtaining ‘normal’ body weight, 
the placentae from these (CBA/CaH × DBA/2J) F1 show altered glycogen storage and considerable T-lymphocyte 
and macrophage inflammatory infiltration compared to (CBA/CaH × Balb/c) F1. These findings suggest that 
there is a range of placental pathology in the CBA/CaH × DBA/2J pregnancy which dictates the fetal outcome; 
severe pathology leads to early resorption, moderate to IUGR at 14.5 dpc with subsequent demise by term, and 
mild which supports live birth.
Among inbred murine strains there is a spectrum of gestational lengths, fetal and placental weights, mater-
nal weight gain and number of concepti29. While gestational length and concepti are largely dependent upon 
maternal genotype29, which was unchanged in our study, fetal and placental weight are dependent on the genetic 
composition of the embryo. Of our three inbred strains, the syngeneic (CBA/CaH × CBA/CaH) F1 had the lowest 
fetal and placental weights of our normal-weight cohorts, consistent with the 14–20% lower fetal and placental 
weight reported in allogeneic vs syngeneic inbred matings30–32. The acquirement of heterosis in F1 fetuses is 
shown to precede implantation, with blastocysts of syngeneic pregnancies containing more cells than allogeneic 
pregnancies at the same gestational age33. As placentation continues the mixed genetic background of the fetuses 
may become more influential with differences in remodelling of the uterine vasculature and maternal immuno-
logical response associated with paternal MHC expression34. Yet, precisely how the mixed genetic background of 
(CBA/CaH × DBA/2J) F1 fetuses leads some to achieve normal-weight while others are growth restricted or die 
is unknown.
Technological advancements and greater appreciation of the placenta as an immunomodulatory organ have 
provided increasing evidence that dysregulation of placentation, and not a loss of maternal immune tolerance 
against the semi-allogeneic fetus per se, underlie human and murine (CBA/J × DB/2JA) IUGR and mortal-
ity8–10,35. Following implantation fetal trophoblasts invade the maternal decidua and partner resident natural 
killer (NK) cells36 to remodel spiral arteries by inducing apoptosis of endothelial cells and vascular smooth muscle 
cells by soluble Fas ligand37–39 and tumour necrosis factor-alpha-related apoptosis-inducing ligand. Apoptotic 
cells are phagocytosed, typically by decidual macrophages, though first trimester trophoblasts are phagocytic40 
and may also play a role in clearing these cells during spiral artery remodelling. Such aberrations in the function 
of the trophoblasts or NK cells results in a failure to convert the maternal spiral arteries into low resistance, high 
capacity vessels39. Subsequent perfusion of the placenta with maternal blood at high pressure incites trophoblast 
damage via shear stress and mechanical damage41 leading to thrombotic and fibrotic events as noted in the IUGR 
placentae of all murine strains in our study, and infarcts, loss of tertiary villi and increased syncytial knots (asso-
ciated with syncytiotrophoblast apoptosis) among the placentae of human IUGR newborns42. Such injury to the 
human placental villi or murine labyrinth reduces the surface area of materno-fetal exchange contributing to 
IUGR.
Delineation of the initial mechanism that renders trophoblasts or decidual NK cells less effective at spiral 
artery remodelling is a relatively new field of research and is complicated by access to very early human placental 
tissue and the differences between invasiveness of murine and human trophoblasts. From the CBA/J × DBA/2J 
model there is evidence of inadequate placentation via poor maternal arterial remodelling at the implantation 
sites8 and perturbations of genomic DNA methylation in the maternal decidua43. Other studies report inflamma-
tory mechanisms, with complement deposition on trophoblasts with increased neutrophil and monocyte infil-
tration and TNF-α expression in maternal decidua and reduced trophoblast giant cells in placentae of resorbing 
fetuses6. Both abnormal DNA methylation and complement deposition appear to distinguish normally develop-
ing fetuses from those which resorb, even within the same litter6,43. Our study compliments this evidence wherein 
perturbations in placental size and morphology were observed in placentae of IUGR fetuses when compared to 
normal-weight littermates. In humans, these parameters dictate the number of maternal spiral arteries that can 
be remodelled and subsequently influences the surface area of nutrient exchange in the placenta44 affecting fetal 
growth and development.
It is understandable that the outcome of any fetus is dependent on the severity of impact to the placenta, as the 
key regulator of both oxygen and nutrients. Mild alterations in placental morphology or inflammation below a 
threshold do not observably impact on weight or CRL but may evoke epigenetic or anatomical changes that alter 
ongoing fetal-adult development. To our knowledge the CBA × DBA model has not been examined as far as pup 
development following birth, largely due to the need to excise uteri and fetuses for assessment of embryonic/
fetal mortality and IUGR. However, as ultrasound biomicroscopy technology becomes more cost-effective, such 
non-invasive assessments of viable vs non-viable murine fetuses on the basis of heart beat45, as well as in situ 
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murine fetal growth measurements46 will be reported and enable long term outcomes to be assessed in this model. 
Of particular note would be cognitive function and behavioural impacts as these are commonly associated with 
children who were IUGR47, despite ‘catching up’ in weight after birth. This will be essential for assessment of novel 
therapeutics to reduce embryonic/fetal mortality and IUGR using the CBA × DBA/2J model.
In summary, we have provided a comprehensive assessment of fetal outcome and placental dimension and 
immune infiltrate temporal and spatial anomalies at two gestational time points (14.5 and 18.5 dpc), with both 
allogeneic and syngeneic control matings, to demonstrate that the CBA/CaH × DBA/J is an equivalent murine 
model of IUGR and embryonic/fetal mortality to the CBA/J × DBA/2J model for assessment of pregnancy pathol-
ogy and/or novel therapeutics.
Methods
Animals and Tissue Preparation. All experiments were approved and performed in accordance with the 
guidelines of the Northern Sydney Local Health District Animal Research Ethics Committee, Australia (ACEC 
1311-015A). Twelve-week old virgin female CBA/CaH.Arc and male CBA/CaH.Arc (H2k), Balb/c.Arc (H2d), and 
DBA/2J.Arc (H2d) mice were purchased from the Animal Resources Centre (Murdoch, Australia). Animals were 
provided food and water ad libitum and kept under specific pathogen-free conditions with controlled humidity 
and light conditions.
Timed syngeneic CBA/CaH × CBA/CaH, and allogeneic CBA/CaH × Balb/c or CBA/CaH × DBA/2J matings 
were performed by pairing females with males overnight. Detection of the vaginal plug denoted 0.5 days post 
coitum (dpc). At 14.5 dpc (mid-gestation; N = 20 dams per strain) and 18.5 dpc (term; N = 30 dams per strain) 
pregnant mice were sacrificed by cervical dislocation and the gravid uteri, including the cervix, were harvested 
and weighed. Subsequently, each fetus and placentae were dissected, weighed, the fetal crown-rump length meas-
ured, and the litter photographed. The number of concepti and embryonic/fetal mortality (resorption) rate were 
also recorded. Embryonic/fetal mortality was defined as including ‘macerated pale fetuses (embryonic)’, bag of 
cells, and ‘clot’18. Pink/perfused fetuses were considered viable. Overall there was ≥ 80% pregnancy success in 
each group. In the term population, two pregnant dams from each group delivered pre-term at 17.5 dpc and were 
excluded from subsequent analyses.
Histology and Immunohistochemistry. Paraffin-embedded tissues. Four μ m sections of 
paraffin-embedded resorptions and placentae were cut sagittal to the midline and stained with haemotoxylin 
and eosin (general morphology), periodic acid Schiff ’s (PAS) procedure (glycogen-positive cells in the tro-
phospongium), or fast-green Masson’s trichrome stain (fibrosis). Immunohistochemistry was performed for 
T-lymphocytes (CD3e; 1 μ g/ml DAKO) and monocyte/macrophages (F4/80; 2 μ g/ml Santa Cruz) following pro-
teinase K (2 mg/ml) antigen retrieval. Normal rat and rabbit IgG served as isotype controls (DAKO).
Frozen tissues. Resorptions and placentae snap-frozen in liquid nitrogen were embedded in Optimal Cutting 
Temperature compound. Eight μ m cryosections were immunohistochemically stained for helper T-lymphocytes 
(CD4; 0.5 μ g/ml Santa Cruz) and cytotoxic T-lymphocytes, CTL (CD8; 0.5 μ g/ml Santa Cruz). Normal rat IgG 
served as isotype control (DAKO).
Placental Structure Quantification. Quantitation of the placental dimensions (diameter, thickness, and 
midline cross-sectional area) were analysed using haemotoxylin and eosin stained sections and the placental 
layers (labyrinth, trophospongium and maternal decidua) using PAS-stained sections. All histological analyses 
were performed using two parallel sections per IUGR and normal-weight placentae taken at least 100 μ m apart. 
Low magnification micrographs were taken using a Nikon Eclipse Ci microscope fitted with a DS-Fi1 digital 
camera and DS-U2 control unit and 2x Plan Achromat objective lenses. From the scale bar placental diameter, 
thickness, and midline cross-sectional area were measured using ImageJ 1.48v software (http://imagej.nih.gov/ij) 
and expressed in millimetres. The area attributed to the labyrinth, trophospongium and maternal decidual layers 
was assessed and expressed as a percentage of the total area of the placenta (excluding fetal circulation structures). 
The percentage of glycogen-containing trophoblasts in PAS-stained sections was quantified by magenta-coloured 
pixels in micrographs using ImageJ 1.48v software (http://imagej.nih.gov/ij). A macro to automate the analy-
sis was modified from the freely available ImageJ resource at http://imagej.net/docs/examples/stained-sections/
index.html (NIH) and utilised the green channel and a magenta colour threshold of (0, max/1.4). For each section 
the data was calculated as the area of magenta coloured pixels/placental midline cross-sectional area*100 and 
expressed as glycogen-containing cells as a proportion (%) of the placental area.
Statistical Analyses. Normality of the data for each outcome was determined by the D’Agostino & Pearson 
omnibus K2 normality test (GraphPad Prism; NIH), except the IUGR 18.5 dpc cohorts due to low sample size 
(normal distribution was assumed using the Central Limit Theorem as the placentae are derived from nor-
mally distributed populations; see Fig. 3b). Data are expressed as mean ± standard error of the mean (SEM). 
Comparison between groups at 14.5 dpc and 18.5 dpc was performed using unpaired two-tailed Student t-test and 
between groups of a single time point by One-way ANOVA with Tukey’s multiple comparison test. Association 
between crown-rump length and fetal weight was determined by Pearson correlation. The Chi square test was 
used to compare the number of concepti between left vs right uterine horns, the frequency of perinatal mortality 
in ‘crowded’ vs ‘uncrowded’ horns, incidence of placentally–fused twins, and differences in proportion of litters 
with resorbing fetuses vs those without. A p-value < 0.05 was considered statistically significant for all analyses.
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